Cepheid Locks Up Two More Patents | GenomeWeb

NEW YORK, April 11 - The US government has awarded Cepheid a patent for its I-CORE technology, which allows for "simultaneous, real-time optical excitation and detection of two or more nucleic acids," and one for a technology that allows for the "automated preparation of biological samples using chip-based microfluidics technology."

To date, Cepheid has 36 US patents either issued or pending, plus corresponding foreign patent applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.